Brochure
5 Sep 2026
Kaisha Lifesciences - Presentation and Current Portfolio
PDF 9.7 MB
• CDMO / CMO for Injectable Finished Formulations
• Ready CTD Dossiers with Zone IVb Stability • New Product Development
Content provided by our supplier
Kaisha Lifesciences Pvt. Ltd
-
Country/Region:India
-
On CPHI since:2019
-
Employees:25 - 49
Company types
Primary activities
Other Content from Kaisha Lifesciences Pvt. Ltd (3)
-
Brochure Pipeline Products with Dossier Readiness Timelines (2027)
General Category SVP's in the Pipeline for 2027 -
Brochure Sovereign Pharma - Presentation
• 100% Contract Manufacturing Facility for SVP's. • We supply over 350 million injections globally. • Approved by EU, PIC/s, UKMHRA -
Brochure KAIVEXIN (Enoxaparin PFS with Sycure AD)
The Efficacious Enoxaparin with Sycure AD AdvantagePrevents misuse of PFSIndividual always receives the right dosage of EnoxaparinHelps to reduce human errorUSDMF grade APIEase of administration